Replies to post #229166 on Biotech Values

[vinmantoo]

i bought RVNC, GSK, KPTI, ESPR and AMZN

Amazon seems like a good choice as people might not go out shopping but order even more stuff from them.

[semi_infinite]

FGEN back to price level of 8/6/2017 just prior to secondary offering prices. Institutions bought all at $29 and 8/7/17 saw prices jump into the 40's. 2.5 years of progress wiped off the books. China health system recovering from covid-19 should get them back on track.

[DewDiligence]

RVNC's sell-off looks overdone; however, there will, IMO, be some delay—possibly material—in RVNC’s obtaining FDA approval in cervical dystonia due to slower than expected patient enrollment in the ASPEN-OLS (open-label safety) study.

The ASPEN-1 (CD efficacy) study probably won’t encounter a material delay insofar as all patients have been enrolled and injected (#msg-154265955).

[swampboots]

Corvid-19 is perfect platform for Amazon to ramp up buying entire landscape, already the most powerful Company in the world.